✦ LIBER ✦

Combination thymosin α1 (Tα1) and lymphoblastoid interferon (L-IFN) therapy in chronic hepatitis C (CHC)

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination low-dose lymphoblastoid inte

✍ G. Rasi; M. G. Mutchnick; D. Di Virgilio; P. Sinibaldi-Vallebona; P. Pierimarchi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 527 KB

Randomized, controlled pilot trial of in

✍ A. Gramenzi; L. Di Giammarino; C. Cursaro; F. Felline; S. Talarico; A. D'Errico; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Predictive factors of disease relapse af

✍ Camps, J; Gareín-Granero, M; Riezu-Boj, J.I.; Larrea, E; de Alsva, E; Civeira, M 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Effectiveness of long term lymphoblastoi

✍ Camps, J.; Castilla, A.; Riezu-Boj, J.I.; Civeira, M.P.; Prieto, J. 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 130 KB

The combination of lymphoblastoid interf

📂 Article 📅 1998 🏛 Adis International Limited (now part of Wolters Kl ⚖ 142 KB

Retreatment of chronic hepatitis C (CHC)

✍ L Chemello; L Cavalletto; E Bernardinello; C Donada; F Belussi; P Casarin; F Urb 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 168 KB